Capsaicin Treatment Attenuates Cholangiocarcinoma Carcinogenesis
Author(s) -
Annika Wutka,
Vindhya Palagani,
Samarpita Barat,
Xi Chen,
Mona El Khatib,
Julian Götze,
Hanane Belahmer,
Steffen Zender,
Przemyslaw Bozko,
Nisar P. Malek,
Ruben R. Plentz
Publication year - 2014
Publication title -
plos one
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.99
H-Index - 332
ISSN - 1932-6203
DOI - 10.1371/journal.pone.0095605
Subject(s) - capsaicin , cancer research , epithelial–mesenchymal transition , pharmacology , carcinogenesis , cell growth , medicine , inflammation , in vivo , cancer , chemistry , biology , receptor , metastasis , biochemistry , microbiology and biotechnology
Capsaicin, the most abundant pungent molecule produced by pepper plants, represents an important ingredient in spicy foods consumed throughout the world. Studies have shown that capsaicin can relieve inflammation and has anti-proliferative effects on various human malignancies. Cholangiocarcinoma (CC) is a cancer disease with rising incidence. The prognosis remains dismal with little advance in treatment. The aim of the present study is to explore the anti-tumor activity of capsaicin in cultured human CC cell lines. Capsaicin effectively impaired cell proliferation, migration, invasion, epithelial to mesenchymal transition and growth of softagar colonies. Further, we show that capsaicin treatment of CC cells regulates the Hedgehog signaling pathway. Conclusion: Our results provide a basis for capsaicin to improve the prognosis of CCs in vivo and present new insights into the effectiveness and mode of action of capsaicin.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom